RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA
Clinical trials for RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test new combo attack on stubborn blood cancers
Disease control CompletedThis early-stage study tested a new combination of two drugs, lenalidomide and blinatumomab, for people with non-Hodgkin lymphoma that had come back or stopped responding to other treatments. The main goal was to find the safest and most effective dose of the drugs when used toge…
Matched conditions: RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for toughest lymphomas: experimental combo targets Cancer's repair system
Disease control CompletedThis early-stage study tested a new combination of drugs for patients with aggressive lymphomas that have come back or not responded to standard treatments. The main goal was to find the safest dose of a drug called olaparib when given with a powerful chemotherapy regimen before …
Matched conditions: RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug aims to boost Cancer-Fighting CAR-T cells
Disease control CompletedThis study tested a drug called NT-I7 in patients with aggressive lymphoma that returned after CAR-T therapy. The main goal was to find a safe dose and see if NT-I7 could help the CAR-T cells last longer and fight the cancer better. The trial involved 17 adults who had already re…
Matched conditions: RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: NeoImmuneTech • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC